DekaBank Deutsche Girozentrale
KALA icon

DekaBank Deutsche Girozentrale’s KALA BIO KALA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$55K – 1445
2021
Q3 		$55K Hold
8
– – ﹤0.01% 1327
2021
Q2 		$107K Hold
8
– – ﹤0.01% 1320
2021
Q1 		$130K Hold
8
– – ﹤0.01% 1255
2020
Q4 		$143K Buy
+8
New +$151K ﹤0.01% 1230

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KALA Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 8 shares — an estimated $55K sold.

DekaBank Deutsche Girozentrale first reported a position in KALA in Q4 2020 and held it in 4 quarters. The position peaked at $143K in Q4 2020. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 8 KALA BIO shares in Q4 2021, an estimated $55K.
  • DekaBank Deutsche Girozentrale first reported a position in KALA BIO in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's KALA BIO position peaked at $143K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.